Ryzodeg combination injection FlexTouch, manufactured by Novo Nordisk Pharma, contains insulin degludec and insulin aspart, which are genetically recombined insulins. This injectable medication, YJ code 2492500G1025, is a soluble insulin product combining basal and rapid-acting insulin, supplied as 300 units per kit.
Ryzodeg combination injection FlexTouch
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →